Cytotoxic triterpenoides from Alismatis Rhizoma

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Alismatis Rhizoma is a traditional herbal medicine.
• Triterpenes are a class of natural compounds with diverse biological activities.
• Cytotoxic compounds are crucial for cancer research and drug development.

Purpose of the Study:

• To isolate and identify bioactive compounds from Alismatis Rhizoma.
• To evaluate the in vitro cytotoxic activity of isolated compounds against various cancer cell lines.

Main Methods:

• Bioassay-guided isolation using in vitro cytotoxic assays.
• Spectroscopic methods (e.g., NMR, MS) for structural elucidation.
• Cytotoxicity assays using SK-OV3, B16-F10, and HT1080 cancer cell lines.

Main Results:

• Four prostane-type triterpenes were successfully isolated and identified: alisol B 23-acetate (1), alisol C 23-acetate (2), alisol B (3), and alisol A 24-acetate (4).
• Alisol B (3) exhibited significant cytotoxicity against SK-OV3, B16-F10, and HT1080 cancer cell lines.
• The ED50 values for alisol B (3) were 7.5 µg/mL against SK-OV3, 7.5 µg/mL against B16-F10, and 4.9 µg/mL against HT1080.

Conclusions:

• Alisol B, a prostane-type triterpene isolated from Alismatis Rhizoma, possesses potent in vitro cytotoxic activity against multiple human and murine cancer cell lines.
• These findings suggest that alisol B is a promising candidate for further investigation as a potential anticancer therapeutic agent.